• SENSEX 74,729.27
    413.66 (+0.56%)
  • BANKNIFTY 55,844.00
    33.50 (+0.06%)
  • Bharti Airtel
    1,909.20 2,174.70(%)
  • Tech Mahindra
    1,797.00 1,850.00(%)
  • The Bombay Burmah
    1,264.85 2,135.00(%)
  • Infosys
    1,166.45 1,727.85(%)
  • Kotak Mah. Bank
    443.70 345.40(%)
  • HBL Engineering
    841.00 1,121.95(%)
  • TCS
    2,482.00 3,336.70(%)
  • NSE
    1,745.10 1,712.00(%)
  • PC Jeweller
    17.13 17.13(%)
  • Reliance Industries
    1,192.75 1,152.30(%)
  • Molbio Diagnosti
    1,675.65 1,686.50(%)
  • HDFC Bank
    724.00 682.00(%)
  • Billionbrains
    203.95 227.00(%)
  • Hyundai Motor I
    2,007.40 2,470.00(%)
  • Max Healthcare
    842.25 842.25(%)
  • Multi Comm. Exc.
    3,123.10 1,761.43(%)
  • SBI Funds Mgt.
    503.70 494.00(%)
  • Nippon ETF Liq.
    1,000.01 1,010.50(%)
  • Clean Max Enviro
    1,292.70 1,532.80(%)
  • ICICI Bank
    1,398.95 1,479.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Symbiotec Pharmalab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 36114.0
  • ISIN : INE899I01028
1,279.50 25 (1.96%)
  • As on 18 Oct 2026 (EOD)

  • Today’s Low

    1,235.00

  • Today’s High

    1,309.90

  • Open

    1,253.00

  • Perv Close

    1,254.90

  • 52W Low

    934.20

  • 52W High

    1,309.90

Key Indicators

  • P/E(TTM)

    52.70

  • Mar.Cap (₹Cr.)

    8,221.57

  • Div & Yield %

    0.00

  • Book Value(₹)

    195.23

  • Debt-Equity Ratio

    1.96

  • AGM Date

    16-Oct-2026

  • EPS

    24.26

  • P/E Ratio

    52.70

Financials Ratios

  • Debt-Equity Ratio

    0.35

  • Mar.Cap (₹Cr.)

    8,221.57

  • RONW (%)

    15.18

  • ROCE (%)

    15.39

Score Board

  • Equity (₹ in Cr.)

    12.85

  • BV (₹)

    195.20

  • Sales( ₹ in Cr.)

    845.17

  • NP (in Cr.)

    155.92

  • NP Var(%)

    7.0

  • Div%

    0.0

  • CPS (₹)

    30.40

  • EPS (₹)

    24.30

  • Traded Value (₹ in Lakhs)

    8,215.14

  • 52 Week High

    1,309.90

  • 52 Week Low

    934.20

  • Price BSE

    1279.0

  • Price NSE

    1,280.00

  • Market Capital( in Cr.)

    8,215.14

  • P/C Ratio

    42.10

  • P/E Ratio

    52.70

  • Price Vs.BV

    24.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 756.68 673.61 563.59 633.85 622.86 531.19
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 756.68 673.61 563.59 633.85 622.86 531.19
Other Income 32.00 19.76 12.37 5.65 9.01 3.17
Stock Adjustments -11.91 -6.33 14.78 1.52 -2.29 56.90
Total Income 776.77 687.04 590.74 641.02 629.58 591.26
EXPENDITURE :            
Raw Materials 288.02 315.25 304.57 359.86 263.81 313.93
Power and Fuel Cost 29.13 31.17 28.75 27.56 24.57 23.21
Employee Cost 119.02 101.60 92.55 81.74 72.77 64.47
Other Manufacturing Expenses 50.54 41.73 33.60 22.05 18.88 17.93
Selling and Administration Expenses 22.41 19.22 20.64 18.42 21.04 26.24
Miscellaneous Expenses 16.63 15.38 82.74 20.44 17.14 22.93
Employee Benefit Expenses 119.02 101.60 92.55 81.74 72.77 64.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 525.75 524.35 562.85 530.06 418.21 468.71
Operating Profit 251.03 162.70 27.89 110.95 211.38 122.56
Interest 16.65 7.54 8.05 3.07 6.52 10.61
Gross Profit 234.38 155.16 19.84 107.88 204.86 111.95
Depreciation 38.36 37.26 27.62 25.11 22.18 21.16
Profit Before Tax 196.02 117.90 -7.78 82.77 182.68 90.79
Current Tax 47.39 28.30 15.16 21.05 46.44 21.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.81 0.65 -0.28 0.00 0.67 -3.28
Reported Net Profit 145.83 88.95 -22.66 61.73 135.56 72.52
Extraordinary Items 0.00 0.01 -79.65 0.00 0.01 -0.21
Adjusted Net Profit 145.83 88.94 56.99 61.73 135.55 72.73
Adjustment below Net Profit -0.48 -0.62 0.29 0.10 -0.04 0.09
P & L Balance brought forward 589.07 500.75 523.11 461.29 325.77 253.16
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 734.43 589.07 500.75 523.11 461.29 325.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 133.35 81.33 -20.72 56.45 123.96 66.31
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 832.83 695.99 615.23 635.68 579.15 455.22
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    33.28%

  • Public Share Holding

    66.72%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 9,819,885 15.28 9,819,885 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,563,938 18.00 11,563,938 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,383,823 33.28 21,383,823 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,433,959 3.79 2,433,959 23
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 690,274 1.07 690,274 6
Mutual Funds / UTI 7,827,702 12.18 7,827,702 13
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12,796,990 19.92 12,796,990 27
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 23,748,925 36.96 23,748,925 69
2] Non Institution
Bodies Corporate 1,224,901 1.91 1,224,901 149
Clearing Members 89,304 0.14 89,304 16
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 627,248 0.98 627,248 344
Foreign Non Institution Other 11,825,492 18.40 11,825,492 3
Hindu Undivided Families 247,471 0.39 247,471 2,356
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 713,198 1.11 713,198 4
Individuals holding nominal share capital up to Rs. 1 lakh 4,302,386 6.70 4,302,386 78,779
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 82,748 0.13 82,748 3
Sub Total 19,123,364 29.76 19,123,364 81,669
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 64,256,112 100.00 64,256,112 81,747

Company Background

Symbiotec Pharmalab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Symbiotec Pharmalab Ltd
  • BSE Code : 36114.0
  • ISIN : INE899I01028

  • Incorporation Year

    2002

  • Registered Office

    385/2 Pigdamber Near
    Mashal Hotel Rau, Indore,
    Madhya Pradesh-453331

  • Telephone

    +91-731-6676405

  • FAX

  • Chairman

    ANIL KUMAR SATWANI

  • Managing Director

  • Company Secretary

    Salil Jain

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Symbiotec Pharmalab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Symbiotec Pharma 1,278.50 788.69 756.68 70.91 20.81
Abbott India 26,154.85 7,217.19 6,929.05 34.42 43.78
Astrazeneca Phar 5,966.05 2,304.07 2,275.58 87.93 27.86
Glaxosmi. Pharma 2,565.20 3,932.76 3,790.20 40.98 58.17
Novartis India 1,900.65 393.10 354.33 48.00 15.94
Cipla 1,325.00 20,102.60 18,979.95 34.82 13.88
Bliss GVS Pharma 658.80 773.53 729.81 61.23 12.51
Amrutanjan Healt 512.65 520.13 502.55 27.46 24.16
Fermenta Biotec. 487.90 474.15 450.25 22.78 18.77
Guj. Themis Bio. 372.10 168.25 165.82 99.49 18.05
Ambalal Sarabhai 38.13 19.52 3.94 70.61 6.77